Articles by Erin Slifka

The impending sale of Arm Holdings to Nvidia for $40 billion could have wide-ranging implications for the global semiconductor industry.

The oil giant doubled down on oil and gas at what now looks to be the worst possible time. Investors are fleeing and workers are grumbling about the direction of a company some see as out of touch.

Central bankers want more stimulus from Congress because new research says spending, not lower rates, would do more to prevent deeper economic scars among the unemployed, businesses and state governments from the pandemic.

U.S. consumer prices rose in August due to higher costs for a range of items, a sign of firmer inflation as demand for goods continues to rebound from a coronavirus pandemic-induced downturn earlier this year.

Two high-ranking executives who oversaw Boeing’s development of the 737 MAX told House investigators the company’s design process wasn’t flawed despite two fatal crashes, a contrast to other company leaders’ concessions of past engineering errors.

The company has ended a pause in clinical trials for its experimental coronavirus vaccine in the U.K. after regulators concluded it was safe to do so. The trials were halted globally after a person who received the vaccine had an unexplained illness.

The biotech drugmaker has a market value of roughly $10 billion, meaning that Gilead would be paying up for the company and its prized breast-cancer drug.

The Japanese technology conglomerate is nearing another big asset sale—of Arm Holdings to Nvidia—that would create a chip-industry powerhouse.

While companies like Uber, Lyft and DoorDash have fought AB-5 in court, the law has unintentionally limited job opportunities for some other freelance workers.

Warner Bros. is postponing the release of its Wonder Woman sequel by more than two months, signaling that Hollywood studios fear U.S. moviegoers are hesitant to return to theaters.